These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 37623221)

  • 1. The Deficits of Insulin Signal in Alzheimer's Disease and the Mechanisms of Vanadium Compounds in Curing AD.
    Yao J; He Z; You G; Liu Q; Li N
    Curr Issues Mol Biol; 2023 Jul; 45(8):6365-6382. PubMed ID: 37623221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Strategies for Treating "Alzheimer's Disease": Insulin Signaling May Be a Feasible Target.
    You G; Yao J; Liu Q; Li N
    Curr Issues Mol Biol; 2022 Dec; 44(12):6172-6188. PubMed ID: 36547082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators.
    Jayaraj RL; Azimullah S; Beiram R
    Saudi J Biol Sci; 2020 Feb; 27(2):736-750. PubMed ID: 32210695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Implication of the Brain Insulin Receptor in Late Onset Alzheimer's Disease Dementia.
    Folch J; Ettcheto M; Busquets O; Sánchez-López E; Castro-Torres RD; Verdaguer E; Manzine PR; Poor SR; García ML; Olloquequi J; Beas-Zarate C; Auladell C; Camins A
    Pharmaceuticals (Basel); 2018 Jan; 11(1):. PubMed ID: 29382127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
    de la Monte SM
    Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease.
    Rad SK; Arya A; Karimian H; Madhavan P; Rizwan F; Koshy S; Prabhu G
    Drug Des Devel Ther; 2018; 12():3999-4021. PubMed ID: 30538427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Protective Effect of Vanadium on Cognitive Impairment and the Neuropathology of Alzheimer's Disease in APPSwe/PS1dE9 Mice.
    He Z; Han S; Zhu H; Hu X; Li X; Hou C; Wu C; Xie Q; Li N; Du X; Ni J; Liu Q
    Front Mol Neurosci; 2020; 13():21. PubMed ID: 32210760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant insulin signaling in Alzheimer's disease: current knowledge.
    Bedse G; Di Domenico F; Serviddio G; Cassano T
    Front Neurosci; 2015; 9():204. PubMed ID: 26136647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling.
    Rhein V; Eckert A
    Arch Physiol Biochem; 2007 Jun; 113(3):131-41. PubMed ID: 17922309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound.
    He Z; You G; Liu Q; Li N
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.
    Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A
    J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Cerebrospinal Fluid CX3CL1 Levels in Alzheimer's Disease Patients but Not in Non-Alzheimer's Disease Dementia.
    Bivona G; Iemmolo M; Piccoli T; Agnello L; Lo Sasso B; Ciaccio M; Ghersi G
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress of RAGE Molecular Imaging in Alzheimer's Disease.
    Kong Y; Liu C; Zhou Y; Qi J; Zhang C; Sun B; Wang J; Guan Y
    Front Aging Neurosci; 2020; 12():227. PubMed ID: 32848706
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.